Drug Trial Radar · NCT04250311
Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults
Last checked: Nov 19, 2026Latest source record: Aug 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Suspended
Enrollment
314
Planned (sponsor's estimate)
Start
Dec 12, 2019
Primary completion
Dec 2024
Study completion Dec 2024
Sponsor
- Lead sponsor
- Materia Medica HoldingIndustry
- Sponsor type
- Industry
- First posted
- Jan 31, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is: • to evaluate the efficacy and safety of MMH-407 in the treatment of influenza in outpatient adults.
Conditions
- Influenza
Interventions
MMH-407Drug
MMH-407: For oral use.
PlaceboDrug
Placebo: For oral use.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to improvement of influenza symptoms.Time frame: On days 1-14 of observation.
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
City Hospital # 5
Barnaul, Russia
Belgorod State National Research University, Hospital Therapy Department
Belgorod, Russia
Road Clinical Hospital at Chelyabinsk station of JSC Russian Railways
Chelyabinsk, Russia
City Clinical Hospital # 9 of the Ministry of Health of the Udmurt Republic
Izhevsk, Russia
Kazan State Medical University, Internal Medicine Department
Kazan', Russia
Kuban State Medical University, Infectious Diseases and Phthisiopulmonology Department
Krasnodar, Russia
Central Clinical Hospital of the Russian Academy of Sciences
Moscow, Russia
City Clinical Hospital # 10 of the Kanavinsky District of Nizhny Novgorod
Nizhny Novgorod, Russia
Road Clinical Hospital at the station Nizhny Novgorod of JSC Russian Railways
Nizhny Novgorod, Russia
Vvedensky City Clinical Hospital
Saint Petersburg, Russia
City Polyclinic # 25 of the Nevsky District
Saint Petersburg, Russia
Medical Center "Reavita Med SPb"
Saint Petersburg, Russia
Llc "Medical Clinic"
Saint Petersburg, Russia
City Polyclinic # 43
Saint Petersburg, Russia
Samara City Hospital # 4
Samara, Russia
Scientific Medical Center for General Therapy and Pharmacology
Stavropol, Russia
Tver State Medical University, Department of Hospital Therapy
Tver', Russia
Bashkir State Medical University, Internal Medicine Department
Ufa, Russia
Volgograd State Medical University
Volgograd, Russia
Altai State Medical University, Department of Faculty Therapy with a course of immunology and allergology
Barnaul, Moscow, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.